Skip to main content
. 2023 Jun 8;17:1647–1659. doi: 10.2147/OPTH.S410471

Table 3.

Change in Medication Burden

Outcome: Medication Burden PEcK Phaco/ECP Phaco/KDB
N Mean (SD) N Mean (SD) N Mean (SD)
Baseline 128 3.0 (1.4) 78 2.2 (1.5) 65 0.4 (1.0)
6 weeks 114 1.7 (1.4) 72 1.3 (1.4) 63 0.4 (1.0)
3 months 79 1.6 (1.3) 58 1.3 (1.4) 41 0.3 (0.7)
6 months 102 1.7 (1.4) 63 1.2 (1.3) 53 0.3 (0.9)
12 months 78 1.9 (1.4) 43 1.4 (1.4) 31 0.3 (0.7)
18 months 56 2.0 (1.4) 30 1.7 (1.3) 18 0.5 (1.0)
24 months 42 2.1 (1.5) 31 1.5 (1.6) 11 0.3 (0.5)
36 months 19 2.1 (1.6) 27 1.5 (1.6) 2 0.0 (0.0)
48 months 3 3.0 (1.0) 14 1.6 (1.5) 0
60 months 0 9 2 (1.5) 0
P-values: Evaluating the pattern of change
 Over time, unadjusted 0.001*
 Over time, adjusteda <0.001*
 Comparing procedure to PEcK over time, unadjusted 0.15 0.04*
 Comparing procedure to PEcK over time, adjusteda 0.09 0.13
 Comparing all procedures over time, unadjusted 0.11
 Comparing all procedures over time, adjusteda 0.17

Notes: Mean medication burden and mean reduction in medications at postoperative timepoints. Wald Tests with and without adjustment for baseline IOP were used to evaluate difference between the pattern of change across timepoints and the pattern of change between all timepoints and the two procedures. aAdjusted GEE for medication burden included co-variates for baseline IOP, prior laser trabeculoplasty, glaucoma type, and sex. *Asterisk identifies significance defined as p < 0.05. All bolded text is used to distinguish column and section headers of the table.

Abbreviations: Phaco/ECP, phacoemulsification and endocyclophotocoagulation (ECP); Phaco/KDB, phacoemulsification and Kahook Dual Blade; PEcK, phacoemulsification, ECP, and KDB.